ITSN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.011600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.030600E-01
Normal-vs-Stage2
3.107400E-01
Normal-vs-Stage3
2.203000E-01
Normal-vs-Stage4
2.993600E-01
Stage1-vs-Stage2
8.491400E-01
Stage1-vs-Stage3
9.300300E-02
Stage1-vs-Stage4
3.684200E-01
Stage2-vs-Stage3
1.062630E-01
Stage2-vs-Stage4
3.178400E-01
Stage3-vs-Stage4
1.076390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.009600E-01
Normal-vs-AfricanAmerican
3.517200E-01
Normal-vs-Asian
2.702800E-01
Caucasian-vs-AfricanAmerican
4.949000E-01
Caucasian-vs-Asian
3.947200E-01
AfricanAmerican-vs-Asian
2.536800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.968800E-01
Normal-vs-Female
3.081000E-01
Male-vs-Female
5.880000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.323000E-01
Normal-vs-Age(41-60Yrs)
3.272600E-01
Normal-vs-Age(61-80Yrs)
2.944400E-01
Normal-vs-Age(81-100Yrs)
2.647400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.160800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.283400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.375200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.716800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.039210E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.331200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.927800E-01
Normal-vs-Daily Drinker
2.614600E-01
Normal-vs-Weekly Drinker
2.794400E-01
Normal-vs-Occasional Drinker
3.030000E-01
Normal-vs-Social Drinker
3.173800E-01
Non Drinker-vs-Daily Drinker
2.937200E-01
Non Drinker-vs-Weekly Drinker
6.783200E-01
Non Drinker-vs-Occasional Drinker
7.823600E-01
Non Drinker-vs-Social Drinker
5.856000E-01
Daily Drinker-vs-Weekly Drinker
7.059200E-01
Daily Drinker-vs-Occasional Drinker
2.308000E-01
Daily Drinker-vs-Social Drinker
1.892430E-01
Weekly Drinker-vs-Occasional Drinker
5.696600E-01
Weekly Drinker-vs-Social Drinker
4.782200E-01
Occasional Drinker-vs-Social Drinker
7.838400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.685500E-02
Normal-vs-Grade 2
1.775950E-03
Normal-vs-Grade 3
4.499600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.622400E-01
Grade 1-vs-Grade 3
1.198350E-01
Grade 1-vs-Grade 4
7.685500E-02
Grade 2-vs-Grade 3
2.678800E-01
Grade 2-vs-Grade 4
1.775950E-03
Grade 3-vs-Grade 4
4.499600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.946600E-01
Normal-vs-NonDiabetic
2.855400E-01
Diabetic-vs-NonDiabetic
7.103000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.807000E-01
Normal-vs-NoPancreatitis
2.885200E-01
Pancreatitis-vs-NoPancreatitis
7.907800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.948600E-01
Normal-vs-N1
3.075200E-01
N0-vs-N1
5.530600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.936800E-01
Normal-vs-TP53-NonMutant
3.000600E-01
TP53-Mutant-vs-TP53-NonMutant
8.420800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
